News Article

Novelties of bioplastics: EC’s policy framework and industry updates

European Commission (EC) publishes policy framework on bio-based, biodegradable, and compostable plastics; aims to guide policy, industry, and public; “bioplastics” should not distract from circular economy principles prioritizing reduction, reuse, recycling; 17th annual European Bioplastics conference gives insights into recent bioplastics’ developments; bioplastics production capacities projected to almost triple by 2027

Publication Peer-reviewed papers

The NORMAN Suspect List Exchange (NORMAN-SLE): facilitating European and worldwide collaboration on suspect screening in high resolution mass spectrometry

Taha H.M., Aalizadeh R., Alygizakis N., Antignac J.P., Arp H.P.H., Bade R., Baker N., Belova L., Bijlsma L., Bolton E.E., Brack W., Celma A., Chen W.L., Cheng T.J., Chirsir P., Cirka L., D'Agostino L.A., Feunang Y.D., Dulio V., Fischer S., Gago-Ferrero P., Galani A., Geueke B., Glowacka N., Gluge J., Groh K., Grosse S., Haglund P., Hakkinen P.J., Hale S.E., Hernandez F., Janssen E.M.L., Jonkers T., Kiefer K., Kirchner M., Koschorreck J., Krauss M., Krier J., Lamoree M.H., Letzel M., Letzel T., Li Q.L., Little J., Liu Y.N., Lunderberg D.M., Martin J.W., McEachran A.D., McLean J.A., Meier C., Meijer J., Menger F., Merino C., Muncke J., Muschket M., Neumann M., Neveu V., Ng K., Oberacher H., O'Brien J., Oswald P., Oswaldova M., Picache J.A., Postigo C., Ramirez N., Reemtsma T., Renaud J., Rostkowski P., Rudel H., Salek R.M., Samanipour S., Scheringer M., Schliebner I., Schulz W., Schulze T., Sengl M., Shoemaker B.A., Sims K., Singer H., Singh R.R., Sumarah M., Thiessen P.A., Thomas K.V., Torres S., Trier X., van Wezel A.P., Vermeulen R.C.H., Vlaanderen J.J., von der Ohe P.C., Wang Z.Y., Williams A.J., Willighagen E.L., Wishart D.S., Zhang J., Thomaidis N.S., Hollender J., Slobodnik J., and Schymanski E.L.
2022, Environmental Sciences Europe
News Article

ECHA finds health benefits outweigh costs of REACH restrictions

European Chemicals Agency (ECHA) study analyzes costs and benefits of REACH restrictions proposed during 2016-2020; finds public health benefits of €2.1 billion per year outweigh costs of €0.5 billion per year; restrictions protect over seven million EU citizens from cancers, sexual development disorders, asthma, skin allergies; prevents annual release of 100 000 tons of polluting chemicals